Is Genmab (GMAB) the High Growth International Stock to Invest in Now?
We recently published a list of 12 High Growth International Stocks to Invest in Now. In this article, we are going to take a ...
Seeking Alpha3d
GNMSF Genmab A/S
Genmab A/S develops antibody therapeutics for ... ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse ...
Barclays Reaffirms Their Buy Rating on Genmab A/S (0MGB)
Barclays analyst Emily Field maintained a Buy rating on Genmab A/S (0MGB – Research Report) today and set a price target of DKK2,100.00. The ...
Genmab A/S (0MGB) Receives a Buy from UBS
In a report released today, Xian Deng from UBS maintained a Buy rating on Genmab A/S (0MGB – Research Report), with a price target of ...
Nasdaq4d
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024
COPENHAGEN, Denmark; January 22, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product ...
Yahoo Finance3d
Grant of Restricted Stock Units and Warrants to Employees in Genmab
COPENHAGEN, Denmark; January 23, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 4,903 restricted stock units and 5,289 warrants to employees of the Company and ...